62 related articles for article (PubMed ID: 11994908)
1. Metformin decreases platelet superoxide anion production in diabetic patients.
Gargiulo P; Caccese D; Pignatelli P; Brufani C; De Vito F; Marino R; Lauro R; Violi F; Di Mario U; Sanguigni V
Diabetes Metab Res Rev; 2002; 18(2):156-9. PubMed ID: 11994908
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
[TBL] [Abstract][Full Text] [Related]
3. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
5. Urinary PC-1 and N-acetyl-beta-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide.
Stefanović V; Antić S; Mitić-Zlatković M; Stojiljković S; Milojković M; Bogicević M; Vlahović P
Ann Clin Biochem; 2003 May; 40(Pt 3):232-4. PubMed ID: 12803833
[TBL] [Abstract][Full Text] [Related]
6. Platelet behaviour in non-insulin-dependent diabetes--influence of vascular complications, treatment and metabolic control.
Peacock I; Hawkins M; Heptinstall S
Thromb Haemost; 1986 Jun; 55(3):361-5. PubMed ID: 3092392
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
[TBL] [Abstract][Full Text] [Related]
8. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
Formoso G; De Filippis EA; Michetti N; Di Fulvio P; Pandolfi A; Bucciarelli T; Ciabattoni G; Nicolucci A; Davì G; Consoli A
Diabetes Metab Res Rev; 2008; 24(3):231-7. PubMed ID: 17966969
[TBL] [Abstract][Full Text] [Related]
9. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
10. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effects of hypoglycemic agents on serum electrolytes in the diabetic patients.
Javaid A; Hasan R; Zaib A; Mansoor S
Pak J Pharm Sci; 2007 Jan; 20(1):67-71. PubMed ID: 17337432
[TBL] [Abstract][Full Text] [Related]
12. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
Medina Santillán R; Reyes-García G; Mateos-García E
Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
[No Abstract] [Full Text] [Related]
13. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin.
Faure P; Wiernsperger N; Polge C; Favier A; Halimi S
Clin Sci (Lond); 2008 Feb; 114(3):251-6. PubMed ID: 17922677
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
15. Total and acylated ghrelin levels in type 2 diabetic patients: similar levels observed after treatment with metformin, pioglitazone or diet therapy.
Kiyici S; Ersoy C; Oz Gul O; Sarandol E; Demirci M; Tuncel E; Sigirli D; Erturk E; Imamoglu S
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):386-90. PubMed ID: 19629933
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
[TBL] [Abstract][Full Text] [Related]
17. Platelet and endothelial function tests during metformin treatment in diabetes mellitus (short communication).
Janka HU
Horm Metab Res Suppl; 1985; 15():120-2. PubMed ID: 2934311
[No Abstract] [Full Text] [Related]
18. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
19. The effects of metformin and glibenclamide on glucose metabolism, counter-regulatory hormones and cardiovascular responses in women with Type 2 diabetes during exercise of moderate intensity.
Cunha MR; da Silva ME; Machado HA; Fukui RT; Correa MR; Santos RF; Wajchenberg BL; Rondon MU; Negrão CE; Ursich MJ
Diabet Med; 2007 Jun; 24(6):592-9. PubMed ID: 17381497
[TBL] [Abstract][Full Text] [Related]
20. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
Medina Santillán R; Reyes-García G; Mateos-García E
Proc West Pharmacol Soc; 2002; 45():137-8. PubMed ID: 12434558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
